Jennifer R Rider
Affiliation: Harvard University
- Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based studyJennifer R Rider
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
Eur Urol 63:88-96. 2013..Limited data exist on long-term outcomes among men with prostate cancer (PCa) from population-based cohorts incorporating information on clinical risk category...
- Seasonal variation in expression of markers in the vitamin D pathway in prostate tissueMara M Epstein
Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA
Cancer Causes Control 23:1359-66. 2012..As serum vitamin D levels vary by season, we sought to determine whether the expression of genes on the vitamin D pathway, assessed in prostate tumor tissue, do the same...
- Temporal trends in cause of death among Swedish and US men with prostate cancerMara M Epstein
Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, 9th Floor, Boston, MA 02115, USA
J Natl Cancer Inst 104:1335-42. 2012..Temporal trends in specific causes of death among prostate cancer patients have not been well described...
- The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysisAndreas Pettersson
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
Cancer Epidemiol Biomarkers Prev 21:1497-509. 2012..Whether the genomic rearrangement transmembrane protease, serine 2 (TMPRSS2):v-ets erythroblastosis virus E26 oncogene homolog (ERG) has prognostic value in prostate cancer is unclear...
- Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up StudyKathryn M Wilson
Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
J Natl Cancer Inst 103:876-84. 2011..Because of these biological activities, coffee may be associated with a reduced risk of prostate cancer...
- Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancerPreet K Dhillon
Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School Boston, MA, USA
Cancer Epidemiol Biomarkers Prev 20:2618-27. 2011..However, the role of genetic variation in the adiponectin (ADIPOQ) and receptor genes (ADIPOR1/R2) in prostate cancer is largely unknown...